The neural transdifferentiation potential of bone marrow mesenchymal stem cells
PLOS One · 20.04.2026 · 21 (4) · e0347119
DOI: 10.1371/journal.pone.0347119 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 20.04.2026. Verfasst von Marie Ytterdal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Cell Transdifferentiation, Bone Marrow Cells, Neurons. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helse Vest.
Abstract (Originalsprache)
Background
Multiple sclerosis is a chronic inflammatory disease of the central nervous system characterized by demyelination and neuronal degeneration. Currently, there is no treatment that can promote remyelination or axonal repair and thus improve patient outcomes. Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic approach in multiple sclerosis due to their regenerative and immunomodulatory properties. Priming MSCs toward neural- or glial-like cells may enhance their therapeutic potential.
Methods
Bone marrow MSCs from multiple sclerosis patients were cultured in differentiation medium containing growth factors for induction of glial and neural transdifferentiating process. Functional assays were used to characterize the proliferation and migration rates of undifferentiated and transdifferentiating MSCs. In addition, immunostaining with five different markers was performed as well as mass spectrometry to investigate and compare protein expressions among the cell types.
Results
Proliferation and migration rates of MSCs decreased in glial and neural transdifferentiating cells. The immunostaining showed expression of neuro-glial markers, and the mass spectrometry data demonstrated substantial variance in protein expression in transdifferentiating MSCs compared to undifferentiated MSCs. Glial and neural markers were upregulated in the transdifferentiating MSCs, while MSC markers were downregulated.
Conclusion
The results demonstrate that MSCs can be guided toward a neuro-glial lineage in vitro and that the transdifferentiating process continues over several weeks. Future research should investigate the in vitro and in vivo therapeutic differences between different transdifferentiating lengths.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.
- Neuro-SysMed, Department of Neurology, Haukeland University Hospital, Bergen, Norway.
- Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
- Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
ORCID-Profile: Marie Ytterdal, Casper Eugen Sandvik
Förderung
- Helse Vest
Zitieren
APA
Ytterdal, M., Sandvik, C. E., Holmøy, T., Bø, L., Kvistad, C. E., & Kråkenes, T. (2026). The neural transdifferentiation potential of bone marrow mesenchymal stem cells. PLOS One, 21(4), e0347119. https://doi.org/10.1371/journal.pone.0347119
Vancouver
Ytterdal M, Sandvik CE, Holmøy T, Bø L, Kvistad CE, Kråkenes T. The neural transdifferentiation potential of bone marrow mesenchymal stem cells. PLOS One. 2026;21(4):e0347119. doi:10.1371/journal.pone.0347119
BibTeX
@article{Ytterdal2026,
author = {Ytterdal, Marie and Sandvik, Casper Eugen and Holmøy, Trygve and Bø, Lars and Kvistad, Christopher Elnan and Kråkenes, Torbjørn},
title = {The neural transdifferentiation potential of bone marrow mesenchymal stem cells},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {4},
pages = {e0347119},
doi = {10.1371/journal.pone.0347119}
}
EUVIMED